Literature DB >> 28932945

Necrostatin-1 Mitigates Endoplasmic Reticulum Stress After Spinal Cord Injury.

Shuang Wang1, Jin Wu1, Yu-Zhe Zeng1, Song-Song Wu1, Guo-Rong Deng2, Zhi-Da Chen1, Bin Lin3.   

Abstract

Necrostatin-1 (Nec-1) has been shown to inhibit necroptosis and convey a significant protective effect after spinal cord injury (SCI). This small molecule inhibitor may reduce tissue damage and restore neurological function by lessening mitochondrial injury after SCI and preserving energy homeostasis. However, the effects of Nec-1 on endoplasmic reticulum stress (ERS)-an important pathological consequence of SCI-are still not clear. The present study investigates the relationship between necroptosis and ERS in a rat model of SCI. Electron microscopy was employed to observe ultra-structural changes in the endoplasmic reticulum and mitochondria after lesioning. Real-time quantitative PCR was used to measure the mRNA levels of ERS-related pro-apoptotic molecules such as C/EBP homologous protein (CHOP), immunoglobulin-binding protein (BiP/GRP78) and X box-binding protein-1 (XBP-1). Western blot and immunofluorescence were conducted to analyze CHOP, GRP78 and XBP-1 protein expression after lesioning. Results demonstrated that applying Nec-1 in SCI reduces ultra-structural damage to the endoplasmic reticulum and mitochondria and inhibits expression of ERS-related genes and proteins after lesioning. Immunofluorescence also shows ERS-related proteins mainly expressed in the cytoplasm of nerve cells. Taken together, these results demonstrate that Nec-1 has protective effect on the endoplasmic reticulum and mitochondria and alleviates ERS after SCI.

Entities:  

Keywords:  BiP/GRP78; CHOP; Endoplasmic reticulum stress; Necroptosis; Necrostatin-1; XBP-1

Mesh:

Substances:

Year:  2017        PMID: 28932945     DOI: 10.1007/s11064-017-2402-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury.

Authors:  Y Wang; H Wang; Y Tao; S Zhang; J Wang; X Feng
Journal:  Neuroscience       Date:  2014-02-20       Impact factor: 3.590

Review 2.  Perspectives on the therapeutic modulation of an alternative cell death, programmed necrosis (review).

Authors:  Young Sik Cho
Journal:  Int J Mol Med       Date:  2014-03-27       Impact factor: 4.101

Review 3.  Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?

Authors:  Margarida V Caldeira; Ivan L Salazar; Michele Curcio; Lorella M T Canzoniero; Carlos B Duarte
Journal:  Prog Neurobiol       Date:  2013-10-22       Impact factor: 11.685

Review 4.  Endoplasmic reticulum stress in liver disease.

Authors:  Harmeet Malhi; Randal J Kaufman
Journal:  J Hepatol       Date:  2010-11-13       Impact factor: 25.083

Review 5.  Review of current evidence for apoptosis after spinal cord injury.

Authors:  M S Beattie; A A Farooqui; J C Bresnahan
Journal:  J Neurotrauma       Date:  2000-10       Impact factor: 5.269

6.  Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response.

Authors:  Clara Penas; Mónica-Sofía Guzmán; Enrique Verdú; Joaquim Forés; Xavier Navarro; Caty Casas
Journal:  J Neurochem       Date:  2007-06-19       Impact factor: 5.372

7.  Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Zerong You; Sean I Savitz; Jinsheng Yang; Alexei Degterev; Junying Yuan; Gregory D Cuny; Michael A Moskowitz; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

8.  Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

Authors:  David P Stirling; Kourosh Khodarahmi; Jie Liu; Lowell T McPhail; Christopher B McBride; John D Steeves; Matt S Ramer; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

Review 9.  Necrosome core machinery: MLKL.

Authors:  Jing Zhang; Yu Yang; Wenyan He; Liming Sun
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

10.  Endoplasmic reticulum stress impairment in the spinal dorsal horn of a neuropathic pain model.

Authors:  Enji Zhang; Min-Hee Yi; Nara Shin; Hyunjung Baek; Sena Kim; Eunjee Kim; Kisang Kwon; Sunyeul Lee; Hyun-Woo Kim; Yong Chul Bae; Yonghyun Kim; O-Yu Kwon; Won Hyung Lee; Dong Woon Kim
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

View more
  6 in total

Review 1.  Estrogenic hormones receptors in Alzheimer's disease.

Authors:  Angeles C Tecalco-Cruz; Jesús Zepeda-Cervantes; Bibiana Ortega-Domínguez
Journal:  Mol Biol Rep       Date:  2021-10-16       Impact factor: 2.316

Review 2.  Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Molecules       Date:  2018-02-13       Impact factor: 4.411

3.  Bone marrow mesenchymal stem cell-derived exosomal microRNA-124-3p attenuates neurological damage in spinal cord ischemia-reperfusion injury by downregulating Ern1 and promoting M2 macrophage polarization.

Authors:  Ran Li; Kunchi Zhao; Qing Ruan; Chunyang Meng; Fei Yin
Journal:  Arthritis Res Ther       Date:  2020-04-09       Impact factor: 5.156

4.  Attenuation of Activated eIF2α Signaling by ISRIB Treatment After Spinal Cord Injury Improves Locomotor Function.

Authors:  Lei Chang; Xiangyang Liu; Jing Chen; Hongzhe Liu; Guoping Wang; Guohua Wang; Xiaoyun Liao; Xiongjie Shen
Journal:  J Mol Neurosci       Date:  2021-10-13       Impact factor: 3.444

Review 5.  Mesenchymal Stem Cell-Derived Exosomal MiRNAs Promote M2 Macrophages Polarization: Therapeutic Opportunities for Spinal Cord Injury.

Authors:  Ze-Yan Liang; Xiong-Jie Xu; Jian Rao; Zhe-Lun Yang; Chun-Hua Wang; Chun-Mei Chen
Journal:  Front Mol Neurosci       Date:  2022-07-12       Impact factor: 6.261

Review 6.  Role of necroptosis in traumatic brain and spinal cord injuries.

Authors:  Xinli Hu; Yu Xu; Haojie Zhang; Yao Li; Xiangyang Wang; Cong Xu; Wenfei Ni; Kailiang Zhou
Journal:  J Adv Res       Date:  2021-12-22       Impact factor: 12.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.